{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:06:10Z","timestamp":1760295970382},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2001,8]]},"DOI":"10.1006\/gyno.2001.6101","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T22:50:18Z","timestamp":1032303018000},"page":"333-337","source":"Crossref","is-referenced-by-count":11,"title":["Phase I Trial of Concomitant Vinorelbine, Paclitaxel, and Pelvic Irradiation in Cervical Carcinoma and Other Advanced Pelvic Malignancies"],"prefix":"10.1006","volume":"82","author":[{"given":"Arno J.","family":"Mundt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Rotmensch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven E.","family":"Waggoner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sister Carole","family":"Langhauser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gini F.","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/gyno.2001.6101_RF1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0090-8258(86)90216-7","article-title":"Radiation therapy alone in the treatment of carcinoma of the uterine cervix: a 20-year experience","volume":"23","author":"Perez","year":"1986","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2001.6101_RF2","first-page":"148","article-title":"Carcinoma of the cervix, stage III","volume":"57","author":"Montanta","year":"1986","journal-title":"Results of radiation therapy. Cancer"},{"key":"10.1006\/gyno.2001.6101_RF3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0002-9378(72)90773-9","article-title":"Stage IV carcinoma of the cervix with bladder invasion","volume":"113","author":"Million","year":"1972","journal-title":"Am J Obstet Gynecol"},{"key":"10.1006\/gyno.2001.6101_RF4","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/jso.2930420211","article-title":"Hydroxyurea plus pelvic irradiation versus placebo plus pelvic irradiation in non-surgically staged IIIB cervical cancer","volume":"42","author":"Piver","year":"1989","journal-title":"J Surg Oncol"},{"key":"10.1006\/gyno.2001.6101_RF5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0360-3016(79)91209-4","article-title":"Hydroxyurea or placebo combined with radiation to treat stages IIIB and IV cervical cancer confined to the pelvis","volume":"5","author":"Hreshchyshyn","year":"1979","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1006\/gyno.2001.6101_RF6","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/0360-3016(85)90092-6","article-title":"The influence of time sequence of updating administration and continuous low dose rate irradiation on their combined effects on a murine squamous cell carcinoma","volume":"11","author":"Fu","year":"1985","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1006\/gyno.2001.6101_RF7","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/1097-0142(19810815)48:4<899::AID-CNCR2820480406>3.0.CO;2-6","article-title":"Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group","volume":"48","author":"Thigpen","year":"1981","journal-title":"Cancer"},{"key":"10.1006\/gyno.2001.6101_RF8","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1200\/JCO.1999.17.5.1339","article-title":"Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB\u2013IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study","volume":"17","author":"Whitney","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.2001.6101_RF9","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM199904153401501","article-title":"Pelvic radiation with concurrent chemotherapy compared with pelvis and para-aortic radiation for high-risk cervical cancer","volume":"340","author":"Morris","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1006\/gyno.2001.6101_RF10","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1056\/NEJM199904153401502","article-title":"Concurrent cisplatin-based chemotherapy and radiotherapy for locally advanced cervical cancer","volume":"340","author":"Rose","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1006\/gyno.2001.6101_RF11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJM199904153401503","article-title":"Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma","volume":"340","author":"Keys","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1006\/gyno.2001.6101_RF12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0090-8258(89)90180-7","article-title":"Concomitant cisplatin and radiotherapy in locally advanced cervical cancer","volume":"34","author":"Runowicz","year":"1989","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2001.6101_RF13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0090-8258(86)90020-X","article-title":"Concurrent weekly cis-platinum and radiotherapy in advanced cervical cancer: a preliminary dose escalating toxicity study","volume":"24","author":"Twiggs","year":"1986","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2001.6101_RF14","first-page":"34","article-title":"Long term follow-up of potentiation of radiotherapy by cis-platinum in advanced cervical cancer","volume":"58","author":"Wong","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2001.6101_RF15","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1200\/JCO.1998.16.3.1094","article-title":"Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix","volume":"16","author":"Morris","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.2001.6101_RF16","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1200\/JCO.1997.15.2.604","article-title":"Vinorelbine as neoadjuvant chemotherapy in advanced cervical carcinoma","volume":"15","author":"Lacava","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.2001.6101_RF17","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0959-8049(99)00237-3","article-title":"Phase II trial of vinorelbine in patients with advanced and\/or recurrent cervical carcinoma: an EORTC Gynaecological Cancer Cooperative Group Study","volume":"36","author":"Lhomme","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.1006\/gyno.2001.6101_RF18","first-page":"792","article-title":"Paclitaxel has moderate activity in squamous cell cancer","volume":"14","author":"McGuire","year":"1996","journal-title":"A Gynecologic Oncology Group study. J Clin Oncol"},{"key":"10.1006\/gyno.2001.6101_RF19","first-page":"41","article-title":"Potentiation of radiotherapy by vinorelbine (Navelbine) in a non-small cell lung cancer","volume":"23","author":"Edelstein","year":"1996","journal-title":"Semin Oncol"},{"key":"10.1006\/gyno.2001.6101_RF20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/gyno.1995.1119","volume":"57","author":"Rodriquez","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2001.6101_RF21","first-page":"19","article-title":"Pilot study of vinorelbine (Navelbine) and paclitaxel in patients with refractory non-small cell lung cancer","volume":"23","author":"Chang","year":"1996","journal-title":"Semin Oncol"},{"key":"10.1006\/gyno.2001.6101_RF22","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/87.14.1072","article-title":"Vinorelbine tartate and paclitaxel combinations: enhanced activity against in vivo P388 murine leukemia cells","volume":"87","author":"Knick","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1006\/gyno.2001.6101_RF23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00001813-199803000-00003","article-title":"The effect of combining antitubulin agents on differentiated and undifferentiated human colon cancer cells","volume":"9","author":"Carles","year":"1998","journal-title":"Anti-Cancer Drugs"},{"key":"10.1006\/gyno.2001.6101_RF24","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0959-8049(97)89023-5","article-title":"In vitro synergy of paclitaxel (Taxol) and vinorelbine (Navelbine) against human melanoma cell lines","volume":"33","author":"Photiou","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1006\/gyno.2001.6101_RF25","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1200\/JCO.1994.12.12.2682","article-title":"Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small cell lung cancer","volume":"12","author":"Choy","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.2001.6101_RF26","first-page":"200","article-title":"Phase I study of paclitaxel and concurrent radiation for locally advanced gastric and pancreatic cancer","volume":"15","author":"Safran","year":"1996","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1006\/gyno.2001.6101_RF27","first-page":"42","article-title":"A summary of vinorelbine (Navelbine) safety data from North American Clinical Trials","volume":"21","author":"Hohneker","year":"1994","journal-title":"Semin Oncol"},{"key":"10.1006\/gyno.2001.6101_RF28","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/0360-3016(94)00635-X","article-title":"The adverse effect of treatment prolongation in cervical carcinoma","volume":"32","author":"Petereit","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1006\/gyno.2001.6101_RF29","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJM199904153401509","article-title":"Improved outcome for cervical cancer\u2014concurrent chemotherapy and radiotherapy","volume":"340","author":"Thomas","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1006\/gyno.2001.6101_RF30","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1200\/JCO.1999.17.5.1334","article-title":"Concurrent chemotherapy and radiation: a major advance for women with cervical cancer","volume":"17","author":"Eifel","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.2001.6101_RF31","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1200\/JCO.1999.17.3.756","article-title":"Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervix","volume":"17","author":"Pignata","year":"1999","journal-title":"J Clin Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825801961013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825801961013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T06:58:44Z","timestamp":1557298724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825801961013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["S0090825801961013"],"URL":"https:\/\/doi.org\/10.1006\/gyno.2001.6101","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2001,8]]}}}